chevron_leftBack
As of 5 June 2026, Merdury Biopharmaceutical Corp. has a market cap of $111.49M USD, ranking #24792 globally and #1313 in Taiwan.
It ranks #2215 in the Healthcare sector, and #801 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$111.49MUSD
3.51B TWD
Enterprise Value
$107.61MUSD
3.39B TWD
EBITDA (TTM)
-$1.9MUSD
-59.67M TWD
Net Income (TTM)
-$2.14MUSD
-67.23M TWD
PB Ratio
16.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Yaoren Liang
open_in_new
Employees
16
Founded
2019
Website
merdury.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.7% | -1% | 2% | -11% | 36% | -39% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
6932
水星生醫股份有限公司
ISIN: TW0006932007
Shares Out.:
Shares Outstanding:
423.791M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
8.17 TWD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Merdury Biopharmaceutical Corp.
Merdury Biopharmaceutical Corporation engages in the development of drugs for unmet needs in Taiwan. The company develops StackDose platform, a drug development technology platform that integrates drug formulation, 3D powder printing, and hardware and software technologies to create drug-specific 3D printing production equipment, which can be used as a foundation for pharmaceutical companies to provide hosted services and in-house product development. Merdury Biopharmaceutical Corporation was founded in 2019 and is headquartered in New Taipei City, Taiwan.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TWSE: 6446
|
$7.8B
7K%
245.34B TWD
|
48.6
|
|
TWSE: 1795
|
$1.84B
2K%
57.95B TWD
|
12.2
|
|
TPEX: 4123
|
$925.55M
730%
29.11B TWD
|
3.4
|
|
TPEX: 6535
|
$809.3M
626%
25.46B TWD
|
-
|
|
TPEX: 4743
|
$789.12M
608%
24.82B TWD
|
-
|
|
TPEX: 4105
|
$584.14M
424%
18.38B TWD
|
11.8
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
683K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
491K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
323K%
|
97.4
|
|
SIX: RO
|
$323.4B
290K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.25B
259K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$276.26B
248K%
218.9B CHF
|
20.5
|
chevron_leftBack